Introduction
autoimmune subepidermal bullous disorder, Dupilumab, atopic dermatitis, Bullous pemphigoid, pruritus, AD
BULLOUS PEMPHIGOID, ATOPIC DERMATITIS, PATHOGENESIS
Bullous pemphigoid (BP) is a common autoimmune subepidermal bullous disorder that primarily affects older people, with tense bullae and pruritus as its characteristic clinical manifestations (The importance of T helper 2 (Th2) cells and the Th2 molecule milieu in the pathogenesis of BP has been demonstrated. Dupilumab is an interleukin (IL)-4 receptor α antagonist that blocks both the IL-4 and IL-13 pathways and has demonstrated efficacy in atopic dermatitis (AD) treatment (